VivoSeq
Other

ACL

0

Pipeline Programs↗

6

Active Trials↗

8

Companies Involved↗

ACL is an early-stage landscape with 0 programs across 8 companies. The most active players are Bristol-Myers Squibb, Conatus Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Bristol-Myers Squibb logo

Bristol-Myers Squibb

0 programs

PreclinicalC

Conatus Pharmaceuticals Inc.

0 programs

PreclinicalMylan Pharmaceuticals Inc logo

Mylan Pharmaceuticals Inc

0 programs

PreclinicalChia Tai Tianqing Pharmaceutical Group Co., Ltd. logo

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalBiogen logo

Biogen

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

28

clinical trials

Completed17 · 61%
Not yet recruiting3 · 11%
Terminated2 · 7%
Unknown status2 · 7%
Withdrawn1 · 4%
Active, not recruiting1 · 4%
Other2 · 7%

Clinical Trials

Trial Activity

28 trials

Long-term Clinical and Radiographic Results of Revision Anterior Cruciate Ligament Reconstruction Using Over The Top Single-bundle Technique and Lateral Extra-articular Tenodesis With Achilles Tendon Allograft.
Recruiting·—·N/A·NCT06868147·59 enrolled
Comparison of Methods in Post Operative Knee Arthroscopy Rehabilitation
Active, not recruiting·UUniversity of Colorado, Denver·Preclinical·NCT05735236·78 enrolled
FNB in ACL Recon Under SA
Not yet recruiting·—·N/A·NCT06048874·100 enrolled
FNB in ACL Recon Under GA
Not yet recruiting·—·N/A·NCT06048848·100 enrolled
Clinical Interventions to Acutely Enhance Quadriceps Output After Anterior Cruciate Ligament Reconstruction
Not yet recruiting·UUniversity of Wisconsin, Madison·Preclinical·NCT07674784·22 enrolled
Menstrual Cycle-Synced Neuromuscular Training
Enrolling by invitation·—·Preclinical·NCT06983184·148 enrolled
Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in Egypt
Completed·—·Phase 4·NCT04773756·54 enrolled
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Completed·PPiramal Critical Care, Ltd.·Phase 3·NCT01520545·153 enrolled
Effect of Low-Dose Baclofen Administration on the GH-IGF1 Axis Study
Completed·US Department of Veterans Affairs·N/A·NCT00871455·20 enrolled
Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State
Completed·Mylan Pharmaceuticals Inc logoMylan Pharmaceuticals Inc·Phase 1·NCT00647738·27 enrolled
Daclatasvir, Asunaprevir Plus Ribavirin for HCV Genotype 1b Without NS5A RAV
Completed·KKaohsiung Medical University Chung-Ho Memorial Hospital·Phase 3·NCT03004625·70 enrolled
A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir
Completed·Bristol-Myers Squibb logoBristol-Myers Squibb·Phase 1·NCT02323594·88 enrolled
Infraclavicular Block Properties in Diabetic Patients
Completed·IIstanbul University·N/A·NCT03486535·60 enrolled
Costoclavicular vs Paracoracoid Approach to Infraclavicular Brachial Plexus Block: a Feasibility Study
Completed·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·N/A·NCT02657291·70 enrolled
Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325
Completed·Bristol-Myers Squibb logoBristol-Myers Squibb·Phase 1·NCT02095860·24 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)